Get Permissions

For permissions, please visit our pages on the Copyright Clearance Center Marketplace.

Popular Now

News

FDA Approves First Pharmacological Treatment for Dementia-Related Agitation

05/11/2023

The FDA has approved the sNDA of REXULTI® (brexpiprazole) for the treatment of agitation associated with dementia related to Alzheimer disease.

The FDA has approved the sNDA of...

05/11/2023

Psych Congress Network

Dr Charles DeBattista Stanford University

MDD Conference Insights

Unmet Needs in MDD Treatment With Dr Charles DeBattista

09/13/2023

Charles DeBattista , MD;

Dr Charles DeBattista, professor of psychiatry and behavioral sciences at Stanford University, discusses the evolving landscape of MDD treatment while on-site at Psych Congress 2023.

Dr Charles DeBattista, professor...

09/13/2023

Psych Congress Network

Videos

Day 2: Late-Breaking Updates From the National Academy of Sciences Conference on Adult ADHD

12/14/2023

Greg Mattingly , MD;

Greg Mattingly, MD, gives exclusive updates from day 2 of the National Academy of Sciences Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development Workshop.

Greg Mattingly, MD, gives...

12/14/2023

Psych Congress Network

Education

Understanding and Implementing Telepsychiatry: Shifting Regulations and Continuing Challenges

06/30/2020

To view accreditation information/faculty disclosures for the program, click HERE. <

To view accreditation...

06/30/2020

Psych Congress Network

News

UHS, Tech Firm Team Up for Pilot to Analyze Patients with AI Software

09/24/2020

Universal Health Services and Eleos Health, a behavioral health tech firm, this week announced the launch of a pilot program for clinical decision-support software to analyze patient experiences and treatment outcomes.

Get Permissions

Popular Now

Sign Up

Specialties

Events

Year Round Education

HMP Global Products